Gaia Fabbri

Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective

L. Voltolini, D. Bennett, E. Bargagli, 2022, Biomedicines.

The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study

E. Bargagli, D. Lacedonia, G. Scioscia, 2023, International journal of molecular sciences.

Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder

G. Parati, R. Scala, M. Girardis, 2023, Respiratory Research.

Holistic management of patients with progressive pulmonary fibrosis

T. Gille, E. Bargagli, M. Wijsenbeek, 2023, Breathe.

Systemic Corticosteroids for Treating Respiratory Diseases: Less Is Better, but… When and How Is It Possible in Real Life?

E. Bargagli, A. Melani, Giusy Montuori, 2023, Pulmonary Therapy.

Inhaled Corticosteroids in Subjects with Chronic Obstructive Pulmonary Disease: An Old, Unfinished History

Maddalena Messina, Gaia Fabbri, Sara Croce, 2024, Biomolecules.

Altered serum concentrations of IL-8, IL-32 and IL-10 in patients with lung impairment 6 months after COVID-19

E. Bargagli, P. Cameli, L. Bergantini, 2024, Immunobiology.